<DOC>
	<DOCNO>NCT02438839</DOCNO>
	<brief_summary>The aim present study investigate whether curative chemoradiation low rectal cancer feasible , safe effective multicenter study result comparable single center study . Results previous study indicate considerable fraction patient low rectal cancer cure combination radiation chemotherapy alone thus spared operation .</brief_summary>
	<brief_title>Curative Chemoradiation Low Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Histopathologically verify adenocarcinoma rectum Planned abdominoperineal resection ( APR ) ultralow resection Primary , resectable T1T3 , N0 tumor . N1 nodal disease acceptable , positive lymph node localize mesorectum level tumor . Distance anal verge lower edge tumor ≤ 6 cm measure rigid rectoscope Performance status 02 Patient acceptance collection biopsy blood sample translational research Age ≥ 18 year Normal function bone marrow evaluate neutrophil ≥ 1.5 x 10^9/l thrombocyte ≥ 100 Normal function liver alanine aminotransferase ( ALAT ) &lt; 2.5 x upper limit normal bilirubin &lt; 2.5 x upper limit normal Kidney function Serum creatinine &lt; 1.5 x upper limit normal measure glomerular filtration rate ( GFR ) &gt; 30 ml/min Fertile woman must present negative pregnancy test use secure contraceptives 3 month treatment . Written orally inform consent Previous surgical treatment present cancer , include transanal excision tumor . Other malignant disease within past five year except basocellular skin cancer carcinoma situ cervicis uteri Distant metastasis verify image biopsy Previous radiation treatment pelvis Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>